IL2 and melanoma: IFN-γ secretion in response to CSPG4+ A375M melanoma cells was enhanced in CAR T cells with engineered SLAMF6 release compared to control CAR T cells (Figure 4D), while IL-2 release was not affected (Figure 4D).